We found immune interactions between tumor cells and T cells decreased after ADT (Figure 5A), including PVR-CD226, similarly, capacity to attract cytotoxic T cell (CXCL12-CXCR4) weakened (Figure 5B). Here, CXCL12 is linked to neoplasm.